Nontuberculous mycobacterial infection after lung transplantation: a report of four cases.
Infection
Lung
NTM
Nontuberculous mycobacteriosis
Transplantation
Journal
Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125
Informations de publication
Date de publication:
23 Jan 2019
23 Jan 2019
Historique:
received:
26
11
2018
accepted:
03
01
2019
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
24
1
2019
Statut:
epublish
Résumé
Nontuberculous mycobacterium (NTM) infection in a patient in an immunosuppressed state caused by increased use of immunosuppressive or biological agents is a serious clinical problem. Mycobacterium avium complex is the most common involved pathogen, followed by Mycobacterium abscessus (MABSC), while Mycobacterium kansasii is not a major concern. The rate of infection rate in lung transplant recipients is reported to range from 1.5-22.4%. We report here four cases of NTM pulmonary infection and disease among 63 patients who underwent lung or heart-lung transplantation at our hospital. Those four occurred following living-donor transplantation in two patients, one with pulmonary arterial hypertension and one with bronchiectasia, and deceased donor lung transplantation in two patients, lymphangioleiomyomatosis and interstitial pneumonia, respectively. NTM was not detected in any of the patients prior to transplantation. The involved pathogens were Mycobacterium gordonae in one, MAC in one, and MABSC in two of these patients, which were isolated from broncho-alveolar lavage (BAL) in two and sputum in two. The one case of MAC and two of MABSC were symptomatic with consolidation shown in chest CT images indicating possible pneumonia, while the one with M. gordonae had no symptoms and was detected by surveillance BAL. Onset time from detection of NTM was greater than 3 years in the three with MABSC and M. gordonae and less than 3 years in the one with MAC. Each patient required a decrease in immunosuppressive agents according to their condition, while antibiotics therapy was performed in the three who were symptomatic. Sputum culture findings became negative after several months and were maintained thereafter in all. An NTM infection leading to pulmonary disease can occur at any time following lung transplantation. Treatment should be considered depending on the involved pathogens, individual status, and disease severity.
Sections du résumé
BACKGROUND
BACKGROUND
Nontuberculous mycobacterium (NTM) infection in a patient in an immunosuppressed state caused by increased use of immunosuppressive or biological agents is a serious clinical problem. Mycobacterium avium complex is the most common involved pathogen, followed by Mycobacterium abscessus (MABSC), while Mycobacterium kansasii is not a major concern. The rate of infection rate in lung transplant recipients is reported to range from 1.5-22.4%.
CASE PRESENTATION
METHODS
We report here four cases of NTM pulmonary infection and disease among 63 patients who underwent lung or heart-lung transplantation at our hospital. Those four occurred following living-donor transplantation in two patients, one with pulmonary arterial hypertension and one with bronchiectasia, and deceased donor lung transplantation in two patients, lymphangioleiomyomatosis and interstitial pneumonia, respectively. NTM was not detected in any of the patients prior to transplantation. The involved pathogens were Mycobacterium gordonae in one, MAC in one, and MABSC in two of these patients, which were isolated from broncho-alveolar lavage (BAL) in two and sputum in two. The one case of MAC and two of MABSC were symptomatic with consolidation shown in chest CT images indicating possible pneumonia, while the one with M. gordonae had no symptoms and was detected by surveillance BAL. Onset time from detection of NTM was greater than 3 years in the three with MABSC and M. gordonae and less than 3 years in the one with MAC. Each patient required a decrease in immunosuppressive agents according to their condition, while antibiotics therapy was performed in the three who were symptomatic. Sputum culture findings became negative after several months and were maintained thereafter in all.
CONCLUSION
CONCLUSIONS
An NTM infection leading to pulmonary disease can occur at any time following lung transplantation. Treatment should be considered depending on the involved pathogens, individual status, and disease severity.
Identifiants
pubmed: 30673890
doi: 10.1186/s40792-019-0565-1
pii: 10.1186/s40792-019-0565-1
pmc: PMC6346695
doi:
Types de publication
Journal Article
Langues
eng
Pagination
11Références
Chest. 1999 Mar;115(3):741-5
pubmed: 10084486
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1611-6
pubmed: 10556129
J Heart Lung Transplant. 2002 Mar;21(3):391-4
pubmed: 11897529
Clin Microbiol Infect. 2003 Jun;9(6):518-25
pubmed: 12848727
J Heart Lung Transplant. 2006 Dec;25(12):1447-55
pubmed: 17178340
Emerg Infect Dis. 2010 Oct;16(10):1576-83
pubmed: 20875283
J Heart Lung Transplant. 2011 Jul;30(7):790-8
pubmed: 21482148
Am J Respir Crit Care Med. 2012 Apr 15;185(8):881-6
pubmed: 22312016
Transpl Infect Dis. 2012 Oct;14(5):452-60
pubmed: 22676720
Thorax. 2016 Jan;71(1):88-90
pubmed: 26678435
Transplantation. 2016 May;100(5):1073-8
pubmed: 26950719
Transpl Infect Dis. 2016 Aug;18(4):585-91
pubmed: 27368989
Science. 2016 Nov 11;354(6313):751-757
pubmed: 27846606
Respir Investig. 2018 May;56(3):243-248
pubmed: 29773296
Clin Infect Dis. 1994 Aug;19(2):263-73
pubmed: 7986898